8 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 8 |
Follow Metaplasia: new trials by email Literature Review of Metaplasia trials Research Report on Metaplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy OCTA plus OCT guided 3+PRN regimen, OCT guided 3+PRN regimen, Anti-VEGF drug - Polypoidal Choroidal Vasculopathy | Phase 4 | Unknown | Xiaodong Sun | 102 | 2020-06-01 | 2020-05-08 |
| Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy Triamcinolone Acetonide, Ranibizumab - Wet Macular Degeneration | Phase 4 | Unknown | Aier School of Ophthalmology, Central South University | 120 | 2017-01-01 | 2018-11-30 |
| Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy ranibizumab - Exudative Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Phase 4 | Unknown | Pusan National University Hospital | 28 | 2016-11-22 | 2019-10-10 |
| Strategies for Management of Corneal Neovascularisation Fine Needle Diathermy, Bevacizumab - Corneal Neovascularisation | Phase 4 | Unknown | University of Nottingham | 40 | 2015-12-01 | 2015-12-02 |
| The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) Conbercept - Polypoidal Choroidal Vasculopathy (PCV) | Phase 4 | Unknown | Chengdu Kanghong Biotech Co., Ltd. | 300 | 2015-10-01 | 2017-07-19 |
| Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization Aflibercept Injection - Choroidal Retinal Neovascularization | Phase 4 | Unknown | Instituto de Olhos de Goiania | 20 | 2013-10-01 | 2014-01-10 |
| PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy Intravitreal Ranibizumabe, panfotocoagulation (PASCAL), panfotocoagulation (PRP) single shoot (ETDRS) - Proliferative Diabetic Retinopathy | Phase 4 | Unknown | University of Sao Paulo | 31 | 2012-02-01 | 2013-12-09 |
| Ranibizumab for Myopic Neovascularization ranibizumab injection - Myopic Choroidal Neovascularization | Phase 4 | Unknown | Instituto de Olhos de Goiania | 20 | 2009-07-01 | 2014-01-01 |
Polypoidal Choroidal Vasculopathy (4) · Myopia (2) · Neovascularization, Pathologic (2) · Corneal Neovascularization (1) · Retinal Neovascularization (1) · Wet Macular Degeneration (1)
Eye Diseases (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Neovascularization, Pathologic (6) · Choroid Diseases (4) · Choroidal Neovascularization (4) · Uveal Diseases (4) · Refractive Errors (2) · Retinal Diseases (2) · Corneal Diseases (1) · Macular Degeneration (1) · Retinal Degeneration (1)
Ranibizumab (3) · Bevacizumab (1) · KH902 fusion protein (1) · Triamcinolone Acetonide (1) · aflibercept (1)
Instituto de Olhos de Goiania (2) · Aier School of Ophthalmology, Central South University (1) · Chengdu Kanghong Biotech Co., Ltd. (1) · Pusan National University Hospital (1) · University of Nottingham (1) · University of Sao Paulo (1) · Xiaodong Sun (1)
Brazil (3) · China (3) · South Korea (1)
Harminder S Dua, Professor (1) · Ji Eun Lee, MD, PhD (1) · Joao J Nassaralla, Jr (1) · Shibo Tang (1) · Xiaodong Sun (1)
2015 (1)